Key opinion leaders: independent experts or drug representatives in disguise?

BMJ. 2008 Jun 21;336(7658):1402-3. doi: 10.1136/bmj.39575.675787.651.

Abstract

Ray Moynihan examines the role of the influential experts paid by industry to help “educate” the profession and the public

MeSH terms

  • Attitude of Health Personnel*
  • Conflict of Interest
  • Drug Industry / economics
  • Drug Industry / ethics*
  • Fees and Charges
  • Leadership
  • Marketing / economics
  • Marketing / ethics*
  • Patient Education as Topic
  • Public Opinion